Advanced Search
LIAN Shengnan, SUN Jingfang, SUN Kaoxiang, LIU Wanhui, CHEN Daquan. Preparation and characterization of oligomeric hyaluronic acid-ketal as a tumour CD44 receptor and pH-sensitive targeting carrier[J]. Journal of China Pharmaceutical University, 2014, 45(5): 540-543. DOI: 10.11665/j.issn.1000-5048.20140506
Citation: LIAN Shengnan, SUN Jingfang, SUN Kaoxiang, LIU Wanhui, CHEN Daquan. Preparation and characterization of oligomeric hyaluronic acid-ketal as a tumour CD44 receptor and pH-sensitive targeting carrier[J]. Journal of China Pharmaceutical University, 2014, 45(5): 540-543. DOI: 10.11665/j.issn.1000-5048.20140506

Preparation and characterization of oligomeric hyaluronic acid-ketal as a tumour CD44 receptor and pH-sensitive targeting carrier

More Information
  • Oligomeric hyaluronic acid(oHA)and ketal was linked by histidine to form a novel oHA-ketal(oHM)carrier with targeting capacity to CD44 receptor and pH sensitivity. The chemical structure of oHM was characterized by 1H NMR and ESI-MS. Some properties, including the formation of micelles, morphology and pH-sensitivity were studied. The oHM can form micelles by self-assembly. The micelles were spherical shape with the diameter about 100 nm, and they also showed some pH-sensitivity. Therefore, oHM could be a potential pH-sensitive tumor targeting carrier to CD44 receptor.
  • [1]
    Morra M.Engineering of biomaterials surfaces by hyaluronan[J]. Biomacromolecules,2005,6(3):1 205-23.
    [2]
    Stern R,Asari AA,Sugahara KN.Hyaluronan fragments:an information-rich system[J]. Eur J Cell Biol,2006,85(8):699-715.
    [3]
    Gerecht S,Burdick JA,Ferreira LS,et al.Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells[J]. Proc Natl Acad Sci USA,2007,104(27):11 298-11 303.
    [4]
    Yu Q,Toole BP,Stamenkovic I.Induction of apoptosis of metastatic mammary carcinoma cells in vivo by disruption of tumor cell surface CD44 function[J]. J Exp Med,1997,186(12):1 985-1 996.
    [5]
    Yasuda M,Tanaka Y,Fujii K,et al.CD44 stimulation down regulates Fas expression and Fas mediated apoptosis of lung cancer cells[J].Int Immunol,2001,13(10):1 309-1 319.
    [6]
    Wang YZ,Cao ML,Liu YW,et al.CD44 mediates oligosaccharides of hyaluronan-induced proliferation,tube formation and signal transduction in endothelial cells[J]. Exp Biol Med,2011,236(1):84-90.
    [7]
    Yang C,Cao M,Liu H,et al.The high and low molecular weight forms of hyaluronan have distinct effects on CD44 clustering[J]. J Biol Chem,2012,287(51):43 094-43 107.
    [8]
    Toole BP.Hyaluronan:from extracellular glue to pericellular cue[J]. Nat Rev Cancer,2004,4(7):528-539.
    [9]
    Jaracz S,Chen J,Kuznetsova LV,et al.Recent advances in tumor-targeting anticancer drug conjugates[J]. Bioorg Med Chem,2005,13(17):5 043-5 054.
    [10]
    Götte M,Yip GW.Heparanase,hyaluronan,and CD44 in cancers:a breast carcinoma perspective[J].Cancer Res,2006,66(21):10 233-10 237.
    [11]
    Choi KY,Min KH,Yoon HY,et al.PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo[J]. Biomaterials,2011,32(7):1 880-1 889.
    [12]
    Heffernan MJ,Murthy N.Polyketal nanoparticles:a new pH-sensitive biodegradable drug delivery vehicle[J].Bioconjug Chem,2005,16(6):1 340-1 342.
  • Related Articles

    [1]SONG Linqi, ZHENG Feng. Preparation, characterization and in vitro release of diclofenac grafted with hyaluronic acid[J]. Journal of China Pharmaceutical University, 2025, 56(1): 49-55. DOI: 10.11665/j.issn.1000-5048.2024072601
    [2]WANG Wendie, ZHOU Jiyuan, TANG Lidan, YIN Tingjie. Preparation and characterization of dasatinib albumin micelles[J]. Journal of China Pharmaceutical University, 2022, 53(3): 286-292. DOI: 10.11665/j.issn.1000-5048.20220305
    [3]SUN Jingfang, GUO Chunjing, ZHANG Yunduan, SONG Xiaoyan, LYU Jiantao, YIN Jungang, CHEN Daquan. Preparation and characterization of multi-functional targeting nano-carrier based on pH-redox tumor microenvironment[J]. Journal of China Pharmaceutical University, 2017, 48(3): 305-310. DOI: 10.11665/j.issn.1000-5048.20170309
    [4]LI Huipeng, SU Zhigui, CHEN Minglei, MENG Fanfei, SUN Minjie, WANG Yan, ZHANG Can, PING Qineng. Preparation and characterization of nanostructured lipid carriers with difference in particle size[J]. Journal of China Pharmaceutical University, 2015, 46(4): 436-443. DOI: 10.11665/j.issn.1000-5048.20150409
    [5]SHI Yongping, SU Zhigui, XIAO Yanyu, SUN Minjie, PING Qineng, ZONG Li. Preparation and characterization of dual-targeting nanostructure lipid carriers loading mitoxantrone hydrochloride for bone tumor[J]. Journal of China Pharmaceutical University, 2013, 44(4): 321-327. DOI: 10.11665/j.issn.1000-5048.20130407
    [6]WANG Jing, GAN Li, GAN Yong, LIU Jianping. Preparation and characterization of hyaluronic acid-modified dexamethasone core-shell liponanoparticles[J]. Journal of China Pharmaceutical University, 2013, 44(2): 117-123. DOI: 10.11665/j.issn.1000-5048.20130204
    [7]Preparation and characterization of N-octyl-N''''-succinyl chitosan as a tumour-targeting carrier[J]. Journal of China Pharmaceutical University, 2007, 38(1): 43-46.
    [9]Preparation and characterization of N-octyl-N'-succinyl chitosan as a tumour-targeting carrier[J]. Journal of China Pharmaceutical University, 2007, 38(1): 6-11.
    [10]Preparation and Characterization of Novel Galactosylated Chitosan[J]. Journal of China Pharmaceutical University, 2003, (5): 1-4.

Catalog

    Article views (1073) PDF downloads (1853) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return